Key clinical point: General and specific recommendations from leading bone health organizations shine a light on how to manage osteoporosis patients during the COVID-19 pandemic.
Major finding: Patients already on osteoporosis medications should continue with treatment, as there is no evidence that these therapies increase the risk of COVID-19 infection.
Study details: A joint statement from five bone health organizations on how to treat patients with osteoporosis.
Disclosures: The authors from the five organizations did not disclose any conflicts of interest.
Joint Guidance on Osteoporosis Management in the Era of Covid-19 From the ASBMR, AACE, Endocrine Society, ECTS & NOF.